BCL9 promotes the proliferation, invasion, migration, angiogenesis, and epithelial–mesenchymal transition of colon cancer cells and multiple myeloma cells, but it does not affect β-catenin protein expression. Here, BCL9 is linked to malignant colon neoplasm.